Skip to main content
Top
Published in: Journal of the International AIDS Society 1/2010

Open Access 01-12-2010 | Research

Targeting the hotspots: investigating spatial and demographic variations in HIV infection in small communities in South Africa

Authors: Handan Wand, Gita Ramjee

Published in: Journal of the International AIDS Society | Issue 1/2010

Login to get access

Abstract

Background

In South Africa, the severity of the HIV/AIDS epidemic varies according to geographical location; hence, localized monitoring of the epidemic would enable more effective prevention strategies. Our objectives were to assess the core areas of HIV infection in KwaZulu-Natal, South Africa, using epidemiological data among sexually active women from localized communities.

Methods

A total of 5753 women from urban, peri-rural and rural communities in KwaZulu-Natal were screened from 2002 to 2005. Each participant was geocoded using a global information system, based on residence at time of screening. The Spatial Scan Statistics programme was used to identify areas with disproportionate excesses in HIV prevalence and incidence.

Results

This study identified three hotspots with excessively high HIV prevalence rates of 56%, 51% and 39%. A total of 458 sexually active women (19% of all cases) were included in these hotspots, and had been exclusively recruited by the Botha's Hill (west of Durban) and Umkomaas (south of Durban) clinic sites. Most of these women were Christian and Zulu-speaking. They were also less likely to be married than women outside these areas (12% vs. 16%, p = 0.001) and more likely to have sex more than three times a week (27% vs. 20%, p < 0.001) and to have had more than three sexual partners (55% vs. 45%, p < 0.001). Diagnosis of genital herpes simplex virus type 2 was also more common in the hotspots. This study also identified areas of high HIV incidence, which were broadly consistent with those with high prevalence rates.

Conclusions

Geographic excesses of HIV infections at rates among the highest in the world were detected in certain rural communities of Durban, South Africa. The results reinforce the inference that risk of HIV infection is associated with definable geographical areas. Localized monitoring of the epidemic is therefore essential for more effective prevention strategies - and particularly urgent in a region such as KwaZulu-Natal, where the epidemic is particularly rampant.
Literature
2.
go back to reference Shisana O, Rehle T, Simbayi LC, Zuma K, Jooste S, Pillay-Van-Wyk V, Mbelle N, Van Zyl J, Parker W, Zungu NP, Pezi S, the SABSSM III Implementation Team: South African national HIV prevalence, incidence, behaviour and communication survey 2008: A turning tide among teenagers?. Pretoria: HSRC Press; 2009. Shisana O, Rehle T, Simbayi LC, Zuma K, Jooste S, Pillay-Van-Wyk V, Mbelle N, Van Zyl J, Parker W, Zungu NP, Pezi S, the SABSSM III Implementation Team: South African national HIV prevalence, incidence, behaviour and communication survey 2008: A turning tide among teenagers?. Pretoria: HSRC Press; 2009.
3.
go back to reference Kleinschmidt I, Pettifor A, Morris N, MacPhail C, Rees H: Geographic Distribution of Human Immunodeficiency Virus in South Africa. American Journal of Tropical Medicine Hygiene 2007, 77 (6) : 1163. Kleinschmidt I, Pettifor A, Morris N, MacPhail C, Rees H: Geographic Distribution of Human Immunodeficiency Virus in South Africa. American Journal of Tropical Medicine Hygiene 2007, 77 (6) : 1163.
4.
go back to reference Lederman MM, Offord RE, Hartley O: Microbicides and other tropical strategies to prevent vaginal transmission oh HIV. Nature Reviews Immunology 2006, 6: 371–382.CrossRefPubMed Lederman MM, Offord RE, Hartley O: Microbicides and other tropical strategies to prevent vaginal transmission oh HIV. Nature Reviews Immunology 2006, 6: 371–382.CrossRefPubMed
5.
go back to reference Nunn A, McCormack S, Crook A, Pool R, Rutterford C, Hayes R: Microbicides Development Programme: Design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention. Trials 2009, 10: 99.CrossRefPubMed Nunn A, McCormack S, Crook A, Pool R, Rutterford C, Hayes R: Microbicides Development Programme: Design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention. Trials 2009, 10: 99.CrossRefPubMed
6.
go back to reference Abdool Karim S, Coletti A, Richardson B, Ramjee G, Hoffman I, Chirenje M, Taha T, Kapina M, Maslankowski L, Soto-Torres L: Safety and effectiveness of vaginal microbicides BufferGel and 0.5% PRO 2000 gel for the prevention of HIV infection in Women: Results of the HPTN 035 trial (Abstract). In 16th Conference on Retroviruses and Opportunistic Infections. Montreal, Canada; 2009. Abdool Karim S, Coletti A, Richardson B, Ramjee G, Hoffman I, Chirenje M, Taha T, Kapina M, Maslankowski L, Soto-Torres L: Safety and effectiveness of vaginal microbicides BufferGel and 0.5% PRO 2000 gel for the prevention of HIV infection in Women: Results of the HPTN 035 trial (Abstract). In 16th Conference on Retroviruses and Opportunistic Infections. Montreal, Canada; 2009.
8.
go back to reference Amar-Roze JM: Geographic inequalities in HIV infection and AIDS in sub-Saharan Africa. Soc Sci Med 1999, 36 (10) : 1247–1256.CrossRef Amar-Roze JM: Geographic inequalities in HIV infection and AIDS in sub-Saharan Africa. Soc Sci Med 1999, 36 (10) : 1247–1256.CrossRef
9.
go back to reference Remy G: Epidemiologic distribution of HIV-2 human immunodeficiency virus infection in sub-Saharan Africa. Med Trop (Mars.) 1993, 53: 511–516. Remy G: Epidemiologic distribution of HIV-2 human immunodeficiency virus infection in sub-Saharan Africa. Med Trop (Mars.) 1993, 53: 511–516.
10.
go back to reference Tanser F, Barnighausen T, Cooke GS, Newell M-L: Localized spatial clustering of HIV infections in a widely disseminated rural South African epidemic. International Journal of Epidemiology 2009, 38 (4) : 1008–1016.CrossRefPubMed Tanser F, Barnighausen T, Cooke GS, Newell M-L: Localized spatial clustering of HIV infections in a widely disseminated rural South African epidemic. International Journal of Epidemiology 2009, 38 (4) : 1008–1016.CrossRefPubMed
11.
go back to reference Aamodt G, Samuelsen SO, Skrondal A: A simulation study of three methods for detecting disease clusters. International Journal of Health Geographics 2006, 5: 15.CrossRefPubMed Aamodt G, Samuelsen SO, Skrondal A: A simulation study of three methods for detecting disease clusters. International Journal of Health Geographics 2006, 5: 15.CrossRefPubMed
12.
go back to reference Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Montgomery ET, Fancher H, Cheng H, Rosenblum M, van der Laan M, Jewell N, McIntyre J, MIRA Team: Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 2007, 370: 251–261.CrossRefPubMed Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Montgomery ET, Fancher H, Cheng H, Rosenblum M, van der Laan M, Jewell N, McIntyre J, MIRA Team: Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 2007, 370: 251–261.CrossRefPubMed
13.
go back to reference Gappoo S, Naidoo S, Ramjee G, Guddera V, Raju E: HSV2 Prevalence Amongst Women Participating in HIV Prevention Studies in rural communities in Durban, South Africa - Urgent need for Microbicide Product to be Active Against HSV2 [Abstract AB14]. In Microbicides 2006 Conference. Durban, South Africa; Gappoo S, Naidoo S, Ramjee G, Guddera V, Raju E: HSV2 Prevalence Amongst Women Participating in HIV Prevention Studies in rural communities in Durban, South Africa - Urgent need for Microbicide Product to be Active Against HSV2 [Abstract AB14]. In Microbicides 2006 Conference. Durban, South Africa;
14.
go back to reference Ramjee G, Kapiga S, Weiss S, Peterson L, Leburg C, Kelly C, Masse B, HPTN 055 Study Team: The value of site preparedness studies for future implementation of phase 2/IIb/III HIV prevention trials: experience from the HPTN 055 study. J Acquir Immune Defic Syndr 2008, 47: 93–100.CrossRefPubMed Ramjee G, Kapiga S, Weiss S, Peterson L, Leburg C, Kelly C, Masse B, HPTN 055 Study Team: The value of site preparedness studies for future implementation of phase 2/IIb/III HIV prevention trials: experience from the HPTN 055 study. J Acquir Immune Defic Syndr 2008, 47: 93–100.CrossRefPubMed
15.
go back to reference Kulldorf M, Song C, Gregoria D, Samociuk H, DeChello L: Cancer map patterns: are they random or not? Am J Prev Med 2006, 30: s37-s49.CrossRef Kulldorf M, Song C, Gregoria D, Samociuk H, DeChello L: Cancer map patterns: are they random or not? Am J Prev Med 2006, 30: s37-s49.CrossRef
16.
go back to reference Kulldorf M: SaTScan 7.0: Software for the spatial and space-time scan statistics: Information Management Services Inc. 2006. Kulldorf M: SaTScan 7.0: Software for the spatial and space-time scan statistics: Information Management Services Inc. 2006.
17.
go back to reference Kulldorf M: Geographical distribution of sporatic Creutzfeldt-Jacob Disease in France. International Journal of Epidemiology 2002, 31: 495–496.CrossRef Kulldorf M: Geographical distribution of sporatic Creutzfeldt-Jacob Disease in France. International Journal of Epidemiology 2002, 31: 495–496.CrossRef
18.
go back to reference Kulldorf M, Zhang Z, Hartman J, Heffernan R, Huang L, Mostashari F: Benchmark Data and Power Calculations for Evaluating Disease Outbreak Detection Methods. MMWR 2004, 53: 144–151. Kulldorf M, Zhang Z, Hartman J, Heffernan R, Huang L, Mostashari F: Benchmark Data and Power Calculations for Evaluating Disease Outbreak Detection Methods. MMWR 2004, 53: 144–151.
19.
go back to reference Song C, Kulldorf M: Power evaluation of disease clustering tests. International Journal of Health Geographics 2003, 2: 9.CrossRefPubMed Song C, Kulldorf M: Power evaluation of disease clustering tests. International Journal of Health Geographics 2003, 2: 9.CrossRefPubMed
20.
go back to reference Nunes C: Tuberculosis incidence in Portugal: spatiotemporal clustering. International Journal of Health Geographics 2007, 6: 30.CrossRefPubMed Nunes C: Tuberculosis incidence in Portugal: spatiotemporal clustering. International Journal of Health Geographics 2007, 6: 30.CrossRefPubMed
21.
go back to reference Ryan JR, Mbui J, Rashid JR, Wasunna MK, Kirigi G, Magiri C, Kinoti D, Ngumbi PM, Martin SK, Odera SO, Hochberg LP, Bautista CT, Chan AS: Spatial clustering and epidemiological aspects of visceral Leishmaniasis in two endemic villages, Baringo District, Kenya. American Journal of Tropical Medicine and Hygiene 2006, 74 (2) : 308–317.PubMed Ryan JR, Mbui J, Rashid JR, Wasunna MK, Kirigi G, Magiri C, Kinoti D, Ngumbi PM, Martin SK, Odera SO, Hochberg LP, Bautista CT, Chan AS: Spatial clustering and epidemiological aspects of visceral Leishmaniasis in two endemic villages, Baringo District, Kenya. American Journal of Tropical Medicine and Hygiene 2006, 74 (2) : 308–317.PubMed
Metadata
Title
Targeting the hotspots: investigating spatial and demographic variations in HIV infection in small communities in South Africa
Authors
Handan Wand
Gita Ramjee
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of the International AIDS Society / Issue 1/2010
Electronic ISSN: 1758-2652
DOI
https://doi.org/10.1186/1758-2652-13-41

Other articles of this Issue 1/2010

Journal of the International AIDS Society 1/2010 Go to the issue